169 related articles for article (PubMed ID: 12057070)
1. Heavy chain disease.
Witzig TE; Wahner-Roedler DL
Curr Treat Options Oncol; 2002 Jun; 3(3):247-54. PubMed ID: 12057070
[TBL] [Abstract][Full Text] [Related]
2. Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update.
Ria R; Dammacco F; Vacca A
Mediterr J Hematol Infect Dis; 2018; 10(1):e2018011. PubMed ID: 29326807
[TBL] [Abstract][Full Text] [Related]
3. Heavy chain diseases.
Wahner-Roedler DL; Kyle RA
Best Pract Res Clin Haematol; 2005; 18(4):729-46. PubMed ID: 16026747
[TBL] [Abstract][Full Text] [Related]
4. [Heavy chain diseases].
Seligmann M
Rev Prat; 1993 Feb; 43(3):317-20. PubMed ID: 8502962
[TBL] [Abstract][Full Text] [Related]
5. Unusual sequence of immunoglobulin L-chain rearrangements in a gamma heavy chain disease patient.
Hauke G; Schiltz E; Bross KJ; Hollmann A; Peter HH; Krawinkel U
Scand J Immunol; 1992 Sep; 36(3):463-8. PubMed ID: 1519038
[TBL] [Abstract][Full Text] [Related]
6. [Heavy chain disease].
Nomura S; Kanoh T
Nihon Rinsho; 1995 Mar; 53(3):730-5. PubMed ID: 7699914
[TBL] [Abstract][Full Text] [Related]
7. Celluar immunoglobulins in human gamma- and alpha-heavy chain diseases.
Preud'homme JL; Brouet JC; Seligmann M
Clin Exp Immunol; 1979 Aug; 37(2):283-91. PubMed ID: 115628
[TBL] [Abstract][Full Text] [Related]
8. Genomic alterations in a case of alpha heavy chain disease leading to the generation of composite exons from the JH region.
Bentaboulet M; Mihaesco E; Gendron MC; Brouet JC; Tsapis A
Eur J Immunol; 1989 Nov; 19(11):2093-8. PubMed ID: 2513209
[TBL] [Abstract][Full Text] [Related]
9. Gamma-heavy chain monoclonal gammopathy with undetermined significance (MGUS).
Zushi Y; Sasaki M; Saitoh T; Aoyama Y; Gotoh Y; Tsunemine H; Kodaka T; Okamura A; Takahashi T
J Clin Exp Hematop; 2019 Sep; 59(3):119-123. PubMed ID: 31391403
[TBL] [Abstract][Full Text] [Related]
10. The productive gene for alpha-H chain disease protein MAL is highly modified by insertion-deletion processes.
Tsapis A; Bentaboulet M; Pellet P; Mihaesco E; Thierry D; Seligmann M; Brouet JC
J Immunol; 1989 Dec; 143(11):3821-7. PubMed ID: 2555418
[TBL] [Abstract][Full Text] [Related]
11. Detection and preparation of immunoglobulin (Ig) mu chain protein in sera of patients with heavy chain diseases (HCD).
Wetter O; Drosdziok W; Müller B
Klin Wochenschr; 1975 Sep; 53(18):885-6. PubMed ID: 809615
[TBL] [Abstract][Full Text] [Related]
12. Heavy-chain diseases.
Fermand JP; Brouet JC
Hematol Oncol Clin North Am; 1999 Dec; 13(6):1281-94. PubMed ID: 10626151
[TBL] [Abstract][Full Text] [Related]
13. Multiple genomic defects result in an alternative RNA splice creating a human gamma H chain disease protein.
Guglielmi P; Bakhshi A; Cogne M; Seligmann M; Korsmeyer SJ
J Immunol; 1988 Sep; 141(5):1762-8. PubMed ID: 3137265
[TBL] [Abstract][Full Text] [Related]
14. Crescentic nodular glomerulosclerosis secondary to truncated immunoglobulin alpha heavy chain deposition.
Cheng IK; Ho SK; Chan DT; Ng WK; Chan KW
Am J Kidney Dis; 1996 Aug; 28(2):283-8. PubMed ID: 8768927
[TBL] [Abstract][Full Text] [Related]
15. Sequential development of Waldenström's macroglobulinemia and gamma-1-heavy chain disease in a single patient. Clinical, immunochemical, immunofluorescent and protein studies.
Ockhuizen T; Jilderda JF; Cazemier T
Acta Haematol; 1984; 71(1):53-9. PubMed ID: 6419527
[TBL] [Abstract][Full Text] [Related]
16. Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors.
Varettoni M; Zibellini S; Capello D; Arcaini L; Rossi D; Pascutto C; Rattotti S; Mangiacavalli S; Pochintesta L; Gotti M; Gaidano G; Cazzola M
Leuk Lymphoma; 2013 Nov; 54(11):2485-9. PubMed ID: 23442064
[TBL] [Abstract][Full Text] [Related]
17. Pre-B-cell development in the absence of lambda 5 in transgenic mice expressing a heavy-chain disease protein.
Corcos D; Dunda O; Butor C; Cesbron JY; Lorès P; Bucchini D; Jami J
Curr Biol; 1995 Oct; 5(10):1140-8. PubMed ID: 8548286
[TBL] [Abstract][Full Text] [Related]
18. Mu-heavy chain disease: presentation as a benign monoclonal gammopathy.
Wahner-Roedler DL; Kyle RA
Am J Hematol; 1992 May; 40(1):56-60. PubMed ID: 1566748
[TBL] [Abstract][Full Text] [Related]
19. Gamma heavy chain disease associated with rheumatoid arthritis: a case report.
Danic G; Dejoie T; Caillon H; Achille A; Pottier P; Agard C
J Med Case Rep; 2021 Mar; 15(1):121. PubMed ID: 33726782
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of mu-heavy chain disease with fludarabine monophosphate: a case report.
Yanai M; Maeda A; Watanabe N; Sugimoto N; Matsushita A; Nagai K; Oida T; Takahashi T
Int J Hematol; 2004 Feb; 79(2):174-7. PubMed ID: 15005347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
